Kanda Junya

カンダジユンヤ | Kanda Junya

Affiliation and department：
Homepage URL (1)： http://kaken.nii.ac.jp/d/r/30636311.ja.html

Research field (1)： Hematology and oncology

Research keywords (5)： Retrospective analysis , Clinical trial , HLA , Cord blood transplantation , Allogeneic hematopoietic stem cell transplantation

Research theme for competitive and other funds (5)：

2023 - 2026 Optimizing immunity in hematopoietic stem cell transplantation focusing on HLA epitopes
2021 - 2024 網羅的なHLA及び臨床情報の機械学習による同種移植の国際標準予後予測アルゴリズム
2018 - 2021 Establishment of an International Standard Algorithm for Improving Umbilical Cord Blood Transplantation Outcomes through Clinical Data Analysis
2014 - 2017 Investigation of redirected Tax-specific T-cell immunotherapy against adult T-cell leukemia/lymphoma
2012 - 2014 Analysis of immune reconstitution after unrelated cord blood transplantation

Papers (394)：

Satoko Morishima, Makoto Yoshimitsu, Takero Shindo, Atae Utsunomiya, Takashi Ishida, Ayumu Ito, Nobuaki Nakano, Toshiro Kawakita, Tetsuya Eto, Youko Suehiro, et al. Individual HLAs affect survival after allogeneic stem cell transplantation in adult T-cell leukaemia/lymphoma. HLA. 2024. 103. 6. e15555
Naokazu Nakamura, Tomoyasu Jo, Yasuyuki Arai, Toshio Kitawaki, Momoko Nishikori, Chisaki Mizumoto, Junya Kanda, Kouhei Yamashita, Miki Nagao, Akifumi Takaori-Kondo. Utilizing red blood cell distribution width (RDW) as a reliable biomarker to predict treatment effects after chimeric antigen receptor T cell therapy. Clinical and Experimental Medicine. 2024. 24. 1
Yutaka Shimazu, Junya Kanda, Yoshiyuki Onda, Shin-Ichi Fuchida, Kensuke Ohta, Yuji Shimura, Satoru Kosugi, Ryosuke Yamamura, Mitsuhiro Matsuda, Hitoshi Hanamoto, et al. The lymphocyte/monocyte ratio predicts the efficacy of isatuximab plus pomalidomide in multiple myeloma patients. Cancer immunology, immunotherapy : CII. 2024. 73. 7. 135-135
Yutaka Shimazu, Junya Kanda, Kazuhito Suzuki, Akinori Wada, Taku Kikuchi, Takashi Ikeda, Nobuhiro Tsukada, Akiyoshi Miwa, Mitsuhiro Itagaki, Shinichi Kako, et al. The impact of daratumumab pretreatment on multiple myeloma patients undergoing autologous transplantation. Cancer science. 2024
Shuhei Kurosawa, Takahiro Fukuda, Tatsuo Ichinohe, Yoshiko Hashii, Junya Kanda, Hideki Goto, Koji Kato, Makoto Yoshimitsu, Fumihiko Ishimaru, Atsushi Sato, et al. Center effect on allogeneic hematopoietic stem cell transplantation outcomes for B-cell acute lymphoblastic leukemia. Cytotherapy. 2024

ｍore...

MISC (133)：

小沼貴晶, 糸永英弘, 石山謙, 土岐典子, 内田直之, 小澤幸泰, 片山雄太, 片岡圭亮, 上田恭典, 松岡賢市, et al. Trends of allogeneic transplant outcomes for adult myelodysplastic syndrome in Japan. 日本造血・免疫細胞療法学会総会プログラム・抄録集. 2022. 45th
小西達矢, 松田健佑, 糸永英弘, 土岐典子, 小澤幸泰, 松岡賢市, 池田宇次, 神田善伸, 福田隆浩, 諫田淳也, et al. Impact of early CMV reactivation on relapse in adult patients with MDS after allogeneic HSCT. 日本造血・免疫細胞療法学会総会プログラム・抄録集. 2022. 45th
黒澤修兵, 下村良充, 下村良充, 糸永英弘, 片山雄太, 鬼塚真仁, 田中正嗣, 小林光, 小澤幸泰, 澤正史, et al. Impact of melphalan dose in patients with MDS undergoing allo-HSCT with RIC. 日本造血・免疫細胞療法学会総会プログラム・抄録集. 2022. 45th
岡村浩史, 岡村浩史, 中前博久, 中前美佳, 中前美佳, 加葉田大志朗, 吉田寿子, 新谷歩, 内田直之, 土岐典子, et al. Personalized transplant strategy guided by machine learning in allogeneic stem cell transplantation. 日本造血・免疫細胞療法学会総会プログラム・抄録集. 2022. 44th
糸永英弘, 木田理子, 土岐典子, 内田直之, 小澤幸泰, 福田隆浩, 上田恭典, 片山雄太, 諫田淳也, 一戸辰夫, et al. Outcomes of allo-HSCT for therapy-related MDS compared to de novo MDS by propensity-score matching. 日本造血・免疫細胞療法学会総会プログラム・抄録集. 2022. 44th

ｍore...

Work history (7)：

2022/04 - 現在 Graduate School of Medicine, Kyoto University Department of Hematology and Oncology Associate Professor
2021/07 - 2022/03 Kyoto University Hospital Hematology and Oncology Medical lecturer
2016/08/01 - Kyoto University Hospital Hematology and Oncology Research Associate
2016/04/01 - Kyoto University Hospital Hematology and Oncology Hospital Assistant
2012/04 - 2016/03 Saitama Medical Center Jichi Medical University Hematology Instructor

Show all

Association Membership(s) (10)：

Cord Blood Connect , Asia Pacific Blood and Marrow Transplantation Group , American Society for Transplantation and Cellular Therapy , American Society of Hematology , Japanese Society of Myeloma , Japanese Society for Histocompatibility and Immunogenetics , The Japan Society of Transfusion Medicine and Cell Therapy , Japanese Society for Transplantation and Cellular Therapy , The Japanese Society of Internal Medicine , The Japanese Society of Hematology

※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page